Supernus Pharmaceuticals Inc 's ability to collect accounts receivable sequentially worsen to 4.35, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Supernus Pharmaceuticals Inc 's Accounts Receivable average collection period in the Sep 30 2026 quarter, has increased to 84 days, from 83 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 428 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2026 from 961 to 2852.

What is Receivable Turnover Ratio?
What is Supernus Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SUPN Receivables Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Receivable Change	25.38 %	50.29 %	25.09 %	32.18 %	17.77 %
Y / Y Revenue Change	18.05 %	32.4 %	38.63 %	21.48 %	9.34 %
Receivable Turnover Ratio (TTM)	4.35	4.41	4.56	4.45	4.55
SUPN's Total Ranking	# 2852	# 961	# 1944	# 854	#
Accounts Receivable average collection period days	84	83	80	82	80
Seq. Receivable Change	1.44 %	16.18 %	-2.99 %	9.66 %	21.6 %
Seq. Revenue Change	3.52 %	5.47 %	-1.83 %	10.13 %	16.11 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 132
Healthcare Sector	# 429
Overall Market	# 2852

Receivable Turnover Ratio Statistics
High	Average	Low
9.44	4.92	0.89
(Sep 30 2014)		(Sep 30 2013)

SUPN Company Profile • Back to SUPN Efficiency Comparisons • Compare SUPN Receivables Turnover Ratio to its Competitors

Financial Statements
Supernus Pharmaceuticals Inc 's Accounts Receivable	$ 215 Millions	Visit SUPN's Balance sheet
Supernus Pharmaceuticals Inc 's Sales TTM	$ 865 Millions	Visit SUPN's Income Statement
Sources of SUPN's Revenues		Visit SUPN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SUPN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SUPN's Growth Rates	SUPN's Roa	SUPN's Inventory Turnover Ratio	SUPN's Dividend Comparisons
SUPN's Profitability Ratios	SUPN's Roi	SUPN's Asset Turnover Ratio	SUPN's Dividend Growth
SUPN's Valuation Ratios	SUPN's Roe	SUPN's Financial Strength Ratios	SUPN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2026	Receivable at quarter ending Sep 30 2026
Iqvia Holdings Inc	10.43	$ 17,311.000 Millions	$ 1,659.500 Millions
Axogen inc	8.71	$ 266.926 Millions	$ 30.654 Millions
Ensign Group Inc	8.62	$ 5,674.305 Millions	$ 658.477 Millions
Intuitive Surgical Inc	7.44	$ 12,115.600 Millions	$ 1,629.350 Millions
Quest Diagnostics Inc	7.43	$ 11,841.000 Millions	$ 1,593.250 Millions
Beta Bionics Inc	7.15	$ 127.899 Millions	$ 17.897 Millions
Angiodynamics Inc	7.13	$ 323.784 Millions	$ 45.418 Millions
Medpace Holdings Inc	6.73	$ 2,838.385 Millions	$ 421.525 Millions
3m Company	6.59	$ 25,247.000 Millions	$ 3,832.500 Millions
Healthcare Services Group Inc	6.36	$ 1,879.860 Millions	$ 295.784 Millions
Integra Lifesciences Holdings Corp	6.26	$ 1,656.786 Millions	$ 264.861 Millions
Neogen Corporation	6.17	$ 884.120 Millions	$ 143.371 Millions
Mimedx Group Inc	6.06	$ 303.363 Millions	$ 50.077 Millions
Avantor Inc	5.98	$ 6,635.600 Millions	$ 1,110.300 Millions
Conmed Corporation	5.76	$ 1,369.288 Millions	$ 237.544 Millions
Clearpoint Neuro Inc	5.75	$ 45.493 Millions	$ 7.906 Millions
Johnson and Johnson	5.45	$ 99,335.000 Millions	$ 18,233.000 Millions
Biomerica Inc	5.17	$ 4.338 Millions	$ 0.838 Millions
Ge Healthcare Technologies Inc	5.11	$ 19,878.000 Millions	$ 3,886.750 Millions
Bausch and Lomb Corp	4.68	$ 5,418.000 Millions	$ 1,158.500 Millions
Orthopediatrics Corp	4.61	$ 263.665 Millions	$ 57.191 Millions
Cryo cell International Inc	4.54	$ 31.127 Millions	$ 6.851 Millions
Glaukos Corp	4.47	$ 578.355 Millions	$ 129.301 Millions
Medinotec Inc	4.05	$ 10.211 Millions	$ 2.524 Millions
Amarin Corp Plcuk	1.50	$ 176.609 Millions	$ 118.128 Millions

Date modified: 2026-10-30T10:06:05+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.